In a disclosure nearly drowned out by news of its $68 billion acquisition of Wyeth, Pfizer Inc. said it agreed to pay $2.3 billion to settle a federal investigation into its alleged off-label marketing of the now-withdrawn painkiller Bextra.
[From Pfizer Sets $2.3 Billion Settlement - WSJ.com]
Pfizer, one of the giants of a health-care sector that had until recently seemed immune from the downturn, said it would cut 8,000 [jobs].
[From Layoffs Cut Deeper Into Economy - washingtonpost.com]
(Emphasis mine)
No comments:
Post a Comment